Clinical Trials

Status
Title Sort ascending Intervention Sponsor Status
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline National Cancer Institute (NCI) Active, not recruiting
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) Placebo, Sulindac 400 MG Duke University Recruiting
Testing Obeticholic Acid for Familial Adenomatous Polyposis Biopsy, Obeticholic Acid, Placebo Administration, Biospecimen Collection, Gastrointestinal Endoscopy, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Atorvastatin Calcium, Biopsy of Colon, Biospecimen Collection, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5, Biopsy, Biospecimen Collection, Colonoscopy, Nogapendekin Alfa, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Questionnaire Administration, Simvastatin, Placebo Administration, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging National Cancer Institute (NCI) Active, not recruiting
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study Lisinopril, Questionnaire Administration, Biospecimen Collection, Liver Ultrasonographic Elastography, Magnetic Resonance Elastography, Magnetic Resonance Imaging, Proton Density Fat Fraction National Cancer Institute (NCI) Recruiting
Obeticholic Acid for Prevention in Barrett's Esophagus Biospecimen Collection, Esophageal Biopsy, Esophagogastroduodenoscopy, Liver Ultrasonographic Elastography, Obeticholic Acid, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Recruiting
GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy, Linaclotide, Plecanatide National Cancer Institute (NCI) Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid National Cancer Institute (NCI) Active, not recruiting